Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P130008/S146

Model 3150 IPG

Inspire Medical Systems · Decision date Oct 13, 2026

MEDTECHLEDGER EXPLANATIONP130008/S146

What did the FDA decide?

The FDA record for P130008/S146, a 30-Day Notice dated 2026-10-13 with decision OK30, describes dimensional changes to the transport fixture used for the Model 3150 Implantable Pulse Generator PCBA. It also covers an added visual inspection of the microcontroller unit before final device assembly. The listed supplement reason is a process change involving manufacturer, sterilizer, packager or supplier; the specialty field is anesthesiology and the product code is MNQ.

The S146 identifier ties this notice to the original P130008 approval for Inspire Medical Systems, but a supplement is not a new approval of the whole system and this is a manufacturing notice, not an original PMA. The statement gives the reported purpose of the changes, not independent proof of safety or clinical effectiveness; it does not describe fixture dimensions, inspection criteria or acceptance limits.

FDA approval order statement

approval for dimensional modifications to the Model 3150 Implantable Pulse Generator (IPG) PCBA transport fixture and the implementation of an additional visual inspection step of the microcontroller unit (MCU) prior to final device assembly
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Anesthesiology
Decision date
Oct 13, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P130008/S146
Regulatory pathway
PMA supplement
Product code
MNQ
Decision code
OK30
Decision date
Oct 13, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, hypoglossal nerve, implanted, apnea.

Product code
MNQ
FDA device class
3

For the original device and its historical approval scope, see PMA P130008. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P130008 · Original PMA

    INSPIRE II UPPER AIRWAY STIMULATOR

  2. P130008/S127 · Related supplement

    MODEL 3150 IMPLANTABLE PULSE GENERATOR (IPG)

  3. P130008/S129 · Related supplement

    Model 2740 Inspire Programmer; Model 2740S/C SleepSync Programming System

  4. P130008/S131 · Related supplement

    Inspire Upper Airway Stimulation

  5. P130008/S130 · Related supplement

    Inspire Upper Airway Stimulation

  6. P130008/S132 · Related supplement

    INSPIRE II UPPER AIRWAY STIMULATOR

  7. P130008/S133 · Related supplement

    QMR Battery Separator Supplier

  8. P130008/S124 · Related supplement

    INSPIRE II UPPER AIRWAY STIMULATOR

  9. P130008/S135 · Related supplement

    Model 3028 Connector Block Laser Weld Inspection Update

  10. P130008/S137 · Related supplement

    Model 3150 Implantable Pulse Generator (IPG)

  11. P130008/S138 · Related supplement

    Inspire V Printed Circuit Board Assembly (PCBA) Test System SW

  12. P130008/S139 · Related supplement

    Inspire Model 4063 Leads; Inspire Model 4340 Leads

  13. P130008/S140 · Related supplement

    Model 3150 Implantable Pulse Generator (IPG)

  14. P130008/S142 · Related supplement

    Model 4063 Inspire Stimulation Lead

  15. P130008/S143 · Related supplement

    Inspire Upper Airway Stimulation (UAS) System

  16. P130008/S123 · Related supplement

    INSPIRE II UPPER AIRWAY STIMULATOR

  17. P130008/S136 · Related supplement

    Model 4063 Inspire Stimulation Lead

  18. P130008/S146 received

    Application receipt date recorded by FDA.

  19. P130008/S146 · FDA decision

    30-Day Notice

  20. P130008/S144 · Related supplement

    INSPIRE II UPPER AIRWAY STIMULATOR

  21. P130008/S148 · Related supplement

    Model 4063 Dedicated Tray Sealer

Timeline entries are records held by MedtechLedger for P130008. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P130008

Product / regulatory recordCompanyPathwayDecision dateSource
Inspire Medical SystemsPMA approvalApr 30, 2014FDA
Inspire Medical SystemsPMA supplementJul 21, 2025FDA
Inspire Medical SystemsPMA supplementSep 29, 2025FDA
Inspire Medical SystemsPMA supplementOct 21, 2025FDA
Inspire Medical SystemsPMA supplementOct 22, 2025FDA
Inspire Medical SystemsPMA supplementDec 17, 2025FDA
Inspire Medical SystemsPMA supplementJan 30, 2026FDA
Inspire Medical SystemsPMA supplementFeb 6, 2026FDA
Inspire Medical SystemsPMA supplementFeb 23, 2026FDA
Inspire Medical SystemsPMA supplementMar 13, 2026FDA
Inspire Medical SystemsPMA supplementApr 16, 2026FDA
Inspire Medical SystemsPMA supplementMay 28, 2026FDA
Inspire Medical SystemsPMA supplementJul 10, 2026FDA
Inspire Medical SystemsPMA supplementAug 11, 2026FDA
Inspire Medical SystemsPMA supplementAug 17, 2026FDA
Inspire Medical SystemsPMA supplementAug 28, 2026FDA
Inspire Medical SystemsPMA supplementAug 28, 2026FDA
Model 3150 IPGP130008/S147
Inspire Medical SystemsPMA supplementOct 22, 2026FDA
Inspire Medical SystemsPMA supplementOct 26, 2026FDA
Inspire Medical SystemsPMA supplementNov 5, 2026FDA

Explore the linked device profile

Other records with product code MNQ

Product / regulatory recordCompanyPathwayDecision dateSource
Genio System 2.1P240024/S004
Nyxoah S.A.PMA supplementJul 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Inspire Medical Systems

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9700 63rd Ave. N., Suite 200, Maple Grove, MN, 55369

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records